Author Interviews, CMAJ, Cost of Health Care, Prostate Cancer / 26.04.2014
Prostate Cancer: Cost Savings from Active Surveillance
MedicalResearch.com Interview with:
Alice Dragomir, MSc, PhD
Assistant Professor,
Urology/Surgery, McGill University
Scientist, RI-MUHC
MedicalResearch.com: What are the main findings of the study?
Authors’ response: Our study demonstrates that for eligible patients, active surveillance could offer not only the known clinical advantages from the patient’s perspective, but also economic benefits from the health care system’s perspective. At the national level, the cost savings of an annual cohort of incident prostate cancers managed with active surveillance over a first year and 5 years of follow-up could be substantial. These are estimated at $96 million.
(more…)